New product commercialization of diagnostic biomarkers and preventative and curative drug therapies for patients, expressly excluding nutritional supplements

Pharmaceutical preparations for the prevention, treatment, and cure of cardiovascular disease; and Pharmaceutical preparations for the treatment of hypertension and heart failure